Semaglutide for cardiovascular event reduction in people with overweight or obesity: SELECT study baseline characteristics

OBJECTIVE: This paper describes the baseline characteristics of the Semaglutide Effects on Heart Disease and Stroke in Patients with Overweight or Obesity (SELECT) study, one of the largest cardiovascular (CV) outcome studies in the field of obesity, which evaluates the effect of semaglutide versus...

Descripción completa

Detalles Bibliográficos
Autores principales: Lingvay, Ildiko, Brown‐Frandsen, Kirstine, Colhoun, Helen M., Deanfield, John, Emerson, Scott S., Esbjerg, Sille, Hardt‐Lindberg, Søren, Hovingh, G. Kees, Kahn, Steven E., Kushner, Robert F., Lincoff, A. Michael, Marso, Steven P., Fries, Tea Monk, Plutzky, Jorge, Ryan, Donna H.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2022
Materias:
ORIGINAL ARTICLES
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10107832/
https://www.ncbi.nlm.nih.gov/pubmed/36502289
http://dx.doi.org/10.1002/oby.23621

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10107832/
https://www.ncbi.nlm.nih.gov/pubmed/36502289
http://dx.doi.org/10.1002/oby.23621

Ejemplares similares